Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

9.690 -0.030 (-0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dynavax Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Preview: Dynavax Technologies's Earnings
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
The 7 Best Stocks Under $15 to Buy in June 2023
While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
The Latest Analyst Ratings for Dynavax Technologies
Via Benzinga
Dynavax Technologies's Return On Capital Employed Insights
Via Benzinga
JMP Securities Maintains Market Outperform Rating for Dynavax Technologies: Here's What You Need To Know
Via Benzinga
Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript
DVAX earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript
DVAX earnings call for the period ending March 31, 2023. 
Via The Motley Fool
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
The Top 7 Growth Stocks in Biotech
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript
DVAX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Co (NYSE: WY) a lot. 
Via Benzinga
China-Based COVID-19 Shot Neutralizes Omicron Subvariants
Via Benzinga
The 7 Most Undervalued Long-Term Stocks to Buy in January
Investors should keep an eye on these severely undervalued long-term stocks as we get deeper into New Year 2023. 
Via InvestorPlace
Our 7 Top Small-Cap Stock Picks for 2023
Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets. 
Via InvestorPlace
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
Via Benzinga
Earnings Preview For Dynavax Technologies
Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
3 Under-the-Radar Small-Cap Stocks With 100% Upside Potential
If under-the-radar small-cap stocks are your jam, I’ve got three selections from the S&P SmallCap 600 that might be right up your alley. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022
Upgrades 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. 
Via Benzinga
Dynavax's Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations
Hong Kong-listed Clover Biopharmaceuticals Ltd announced data from a global Phase 2/3 trial evaluating its COVID-19 vaccine candidate, SCB-2019, in adolescents (aged 12 to 17 years).  
Via Benzinga
Rocket Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
On Thursday, Rocket Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 88 to 94. 
Via Investor's Business Daily
Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90
On Monday, Kura Oncology stock had its Relative Strength (RS) Rating upgraded to 91, up from 85 a day earlier. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.